| Microsatellite Stable Colorectal Carcinoma studied in …STUDIED_INderived10 of 24show all (up to 200) |
|---|
| → studied in | NCT07363408Phase 1 · not yet recruiting Ivonescimab and ADG126, Alone, and in Combination With Leucovorin and Fluorouracil or FOLFIRI Regimen for the Treatment of Microsatellite Stable Advanced/Metastatic Colorectal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05627635Phase 1/Phase 2 · active not recruiting FOLFOX and Bevacizumab in Combination With Botensilimab and Balstilimab (3B-FOLFOX) for the Treatment of Microsatellite Stable (MSS) Metastatic Colorectal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05672316Phase 1/Phase 2 · active not recruiting Botensilimab, Balstilimab and Regorafenib for the Treatment of Patients With Microsatellite Stable Metastatic Colorectal Cancer Who Have Progressed on Prior Chemotherapy · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07735624Phase 2 · recruiting RECTIFY-1: Neoadjuvant Botensilimab + Balstilimab in MSS/pMMR Early Rectal Cancer · condition mapped ONTOLOGY_EXACT · 24 trials mapped (16 active) | — | — | Microsatellite Stable Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04354246Phase 1 · completed COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies · condition mapped ONTOLOGY_EXACT · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05691491Phase 1/Phase 2 · recruiting Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654037Phase 1 · recruiting Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05710406Phase 2/Phase 3 · active not recruiting Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer · condition mapped ONTOLOGY_EXACT · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colon Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06843434Phase 2 · recruiting A Study of Botensilimab and Balstilimab for Rectal Adenocarcinoma · condition mapped ONTOLOGY_EXACT · 24 trials mapped (16 active) | — | — | Microsatellite Stable Rectal Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04017650Phase 1/Phase 2 · active not recruiting Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer · condition mapped CURATED_BROADER · 24 trials mapped (16 active) | — | — | Microsatellite Stable Colorectal Carcinoma | 1 | Observed | clinicaltrials | graph → |